David Bell
No más puestos en curso
Perfil
David Bell worked as the Head of Mass Spec Operations at Oxford BioTherapeutics Ltd.
and as a Principal at GSK Plc.
Antiguos cargos conocidos de David Bell.
| Empresas | Cargo | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Chief Operating Officer | 03/05/2012 |
Experiencias
Funciones ocupadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GSK PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- David Bell
